DrugPatentWatch Database Preview
Actavis Labs Fl Inc Company Profile
What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?
ACTAVIS LABS FL INC has seventy-one approved drugs.
There are two tentative approvals on ACTAVIS LABS FL INC drugs.
Summary for Actavis Labs Fl Inc
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 71 |
Drugs and US Patents for Actavis Labs Fl Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 203693-003 | Oct 16, 2017 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | POTASSIUM CHLORIDE | potassium chloride | TABLET, EXTENDED RELEASE;ORAL | 075604-002 | Apr 10, 2002 | AB1 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 206470-002 | Jun 2, 2016 | AA | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Actavis Labs Fl Inc | HYDROCODONE BITARTRATE AND IBUPROFEN | hydrocodone bitartrate; ibuprofen | TABLET;ORAL | 077454-001 | Jun 23, 2010 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Actavis Labs Fl Inc | BENAZEPRIL HYDROCHLORIDE | benazepril hydrochloride | TABLET;ORAL | 076267-003 | Feb 11, 2004 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Actavis Labs Fl Inc | RISPERIDONE | risperidone | TABLET, ORALLY DISINTEGRATING;ORAL | 076996-002 | Apr 19, 2011 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
